Neuroprotective agents

The neurotrophic and neuroprotective effects of psychotropic agents.
[19877500] Dialogues Clin Neurosci 11(3): 333-48 (2009)

Neuroprotective effects of propofol in acute cerebral injury.
[17894649] CNS Drug Rev 13(3): 333-51 (2007)

Pharmacological properties of BN82451: a novel multitargeting neuroprotective agent.
[17894648] CNS Drug Rev 13(3): 317-32 (2007)

Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor.
[11474423] CNS Drug Rev 7(2): 172-98 (2001)

Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.
[17047683] J Cereb Blood Flow Metab 27(6): 1108-28 (2007)

Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades.
[11973422] J Cereb Blood Flow Metab 22(5): 503-14 (2002)

Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.
[11524608] J Cereb Blood Flow Metab 21(9): 1013-33 (2001)

Estrogen as a neuroprotectant in stroke.
[10779008] J Cereb Blood Flow Metab 20(4): 631-52 (2000)

Neuroprotective role of mitochondrial uncoupling protein 2 in cerebral stroke.
[19240738] J Cereb Blood Flow Metab 29(6): 1069-78 (2009)

Novel mechanisms and approaches in the study of neurodegeneration and neuroprotection. a review.
[14715440] Neurotox Res 5(6): 375-83 (2003)

Brain protection: physiological and pharmacological considerations. Part II: The pharmacology of brain protection.
[2225293] Can J Anaesth 37(7): 762-77 (1990)

Triflusal: an antiplatelet drug with a neuroprotective effect?
[16939630] Cardiovasc Drug Rev 24(1): 11-24 (2006)

Progesterone for the treatment of experimental brain injury; a systematic review.
[17715141] Brain 131(Pt 2): 318-28 (2008)

Neuroprotective effects of antidepressant and mood stabilizing drugs.
[11836978] J Psychiatry Neurosci 27(1): 8-9 (2002)

Neuroprotection and acute spinal cord injury: a reappraisal.
[15717009] NeuroRx 1(1): 80-100 (2004)

Critical appraisal of neuroprotection trials in head injury: what have we learned?
[15717008] NeuroRx 1(1): 71-9 (2004)

Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies.
[15717003] NeuroRx 1(1): 5-16 (2004)

Current status of neuroprotection for cerebral ischemia: synoptic overview.
[19064810] Stroke 40(3 Suppl): S111-4 (2009)

Neuronal cell death in nervous system development, disease, and injury (Review).
[11295106] Int J Mol Med 7(5): 455-78 (2001)

Novel neuroprotective strategies in ischemic retinal lesions.
[20386654] Int J Mol Sci 11(2): 544-61 (2010)

Unconventional neurotransmitters, neurodegeneration and neuroprotection.
[19219299] Braz J Med Biol Res 42(1): 68-75 (2009)

The search for neuroprotective strategies in stroke.
[14970016] AJNR Am J Neuroradiol 25(2): 181-94 (2004)

Mitochondrial mechanisms of estrogen neuroprotection.
[19931595] Biochim Biophys Acta 1800(10): 1113-20 (2010)

Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system.
[17431228] Endocr Rev 28(4): 387-439 (2007)

Mitochondria, oxidative stress and PARP-1 network: a new target for neuroprotective effects of tetracyclines?
[18372301] J Physiol 586(10): 2427-8 (2008)

Neuropsychotoxic and neuroprotective potentials of dextromethorphan and its analogs.
[21606622] J Pharmacol Sci 116(2): 137-48 (2011)

Neuropsychotoxicity of abused drugs: potential of dextromethorphan and novel neuroprotective analogs of dextromethorphan with improved safety profiles in terms of abuse and neuroprotective effects.
[18198471] J Pharmacol Sci 106(1): 22-7 (2008)

The endocannabinoid system as a target for the treatment of neurodegenerative disease.
[20590559] Br J Pharmacol 160(3): 480-98 (2010)

Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection.
[20128800] Br J Pharmacol 159(3): 495-501 (2010)

IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions.
[19438508] Br J Pharmacol 157(6): 881-91 (2009)

Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly.
[18059324] Br J Pharmacol 153 Suppl 1(-): S325-38 (2008)

Endogenous neuroprotective factors: neurosteroids.
[16845207] Pharmacol Rep 58(3): 335-40 (2006)

Role of vinpocetine in cerebrovascular diseases.
[21857073] Pharmacol Rep 63(3): 618-28 (2011)

Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.
[15985713] Pharmacol Rep 57(3): 307-20 (2005)

The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease.
[21340000] Int J Mol Sci 12(1): 506-69 (2011)

Estrogens and progesterone as neuroprotectants: what animal models teach us.
[17981614] Front Biosci 13(-): 1083-9 (2008)

Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries.
[21274503] Mol Med 17(5-6): 448-56 (2011)

The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies.
[18845187] Brain Res Rev 59(2): 293-315 (2009)

Progesterone exerts neuroprotective effects after brain injury.
[17826842] Brain Res Rev 57(2): 386-97 (2008)

Drugs acting on SUR1 to treat CNS ischemia and trauma.
[18032110] Curr Opin Pharmacol 8(1): 42-9 (2008)

Acid-sensing ion channels (ASICs) as pharmacological targets for neurodegenerative diseases.
[17945532] Curr Opin Pharmacol 8(1): 25-32 (2008)

Neuroglobin: an endogenous neuroprotectant.
[17942367] Curr Opin Pharmacol 8(1): 20-4 (2008)

A dibenzoylmethane derivative protects dopaminergic neurons against both oxidative stress and endoplasmic reticulum stress.
[17913843] Am J Physiol Cell Physiol 293(6): C1884-94 (2007)

Widespread cortical expression of MANF by AAV serotype 7: localization and protection against ischemic brain injury.
[20685313] Exp Neurol 225(1): 104-13 (2010)

Prospects for minocycline neuroprotection.
[20697034] Arch Neurol 67(12): 1442-8 (2010)

Neuroprotection: challenges and opportunities.
[17562927] Arch Neurol 64(6): 794-800 (2007)

Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors.
[17965746] Br J Pharmacol 152(8): 1301-11 (2007)

A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury.
[20146558] J Neurotrauma 28(8): 1545-88 (2011)

Neurotoxins: free radical mechanisms and melatonin protection.
[21358970] Curr Neuropharmacol 8(3): 194-210 (2010)

Clearing the brain's cobwebs: the role of autophagy in neuroprotection.
[19305790] Curr Neuropharmacol 6(2): 97-101 (2008)

Resveratrol as a therapeutic agent for neurodegenerative diseases.
[20306310] Mol Neurobiol 41(2-3): 375-83 (2010)

Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection.
[20157789] Mol Neurobiol 41(2-3): 172-9 (2010)

Neuroprotection by spice-derived nutraceuticals: you are what you eat!
[21360003] Mol Neurobiol 44(2): 142-59 (2011)

P2Y2 nucleotide receptor-mediated responses in brain cells.
[20387013] Mol Neurobiol 41(2-3): 356-66 (2010)

Multiple roles of HDAC inhibition in neurodegenerative conditions.
[19775759] Trends Neurosci 32(11): 591-601 (2009)

Erythropoietin for infants with hypoxic-ischemic encephalopathy.
[20090525] Curr Opin Pediatr 22(2): 139-45 (2010)

Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration.
[19145989] Rev Neurosci 19(4-5): 341-61 (2008)

Citicoline: pharmacological and clinical review, 2010 update.
[21432836] Rev Neurol 52 Suppl 2(-): S1-S62 (2011)

Magnesium sulphate for fetal neuroprotection.
[21877014] Rev Bras Ginecol Obstet 33(6): 265-70 (2011)

Potential future neuroprotective therapies for neurodegenerative disorders and stroke.
[20176298] Clin Geriatr Med 26(1): 125-47 (2010)

Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit.
[18696266] Neurocrit Care 10(1): 103-15 (2009)

Recent trends in erythropoietin-mediated neuroprotection.
[17936539] Int J Dev Neurosci 26(1): 103-11 (2008)

Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies.
[18396368] Prog Neurobiol 85(2): 194-213 (2008)

Proinsulin: from hormonal precursor to neuroprotective factor.
[21949502] Front Mol Neurosci 4(-): 20 (2011)

Neuroprotective actions of androgens on motoneurons.
[19393684] Front Neuroendocrinol 30(2): 130-41 (2009)

Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies.
[20831615] J Neurochem 115(4): 806-13 (2010)

Administration of thiazolidinediones for neuroprotection in ischemic stroke: a pre-clinical systematic review.
[20964688] J Neurochem 115(4): 845-53 (2010)

In search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?
[17572175] Biol Psychiatry 62(1): 4-6 (2007)

GDNF and protection of adult central catecholaminergic neurons.
[21357726] J Mol Endocrinol 46(3): R83-92 (2011)

Selective estrogen receptor modulators as brain therapeutic agents.
[21071476] J Mol Endocrinol 46(1): R1-9 (2011)

Complement in neuroprotection and neurodegeneration.
[20116331] Trends Mol Med 16(2): 69-76 (2010)

HSP27: mechanisms of cellular protection against neuronal injury.
[19860665] Curr Mol Med 9(7): 863-72 (2009)

Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.
[19527737] Life Sci 86(15-16): 615-23 (2010)

Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.
[17379265] Steroids 72(5): 381-405 (2007)

Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke.
[19137430] Apoptosis 14(4): 469-77 (2009)

Control of intracellular calcium signaling as a neuroprotective strategy.
[20335972] Molecules 15(3): 1168-95 (2010)

Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implications.
[21163293] Front Neuroendocrinol 32(3): 336-52 (2011)

Neuroprotection and recovery: recent data at the bench on citicoline.
[21164125] Stroke 42(1 Suppl): S33-5 (2011)

Citicoline in vascular cognitive impairment and vascular dementia after stroke.
[21164117] Stroke 42(1 Suppl): S40-3 (2011)

New approaches to neuroprotective drug development.
[21164111] Stroke 42(1 Suppl): S24-7 (2011)

Toll-like receptor tolerance as a mechanism for neuroprotection.
[21339866] Transl Stroke Res 1(4): 252-260 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Neuroprotective agents.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Neuroprotective agents.php on line 92